Import Alert 55-03
(Note: This import alert represents the Agency's current guidance to FDA field personnel regarding the manufacturer(s) and/or products(s) at issue. It does not create or confer any rights for or on any person, and does not operate to bind FDA or the public).
Import Alert # 55-03
Published Date: 01/18/2024
Type: DWPE
Import Alert Name:
DETENTION WITHOUT PHYSICAL EXAMINATION OF DIFFERENT FORMS OF HEPARIN AND HEPARIN-RELATED PRODUCTS
Reason for Alert:
Revision to this Import Alert dated July 21, 2014 revises the Reason for Alert section, the Guidance section, and the Charge Code, to include authority set forth in section 501(j) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) making a drug adulterated if it has been manufactured, processed, packed, or held in any factory, warehouse, or establishment and the owner, operator, or agent of such factory, warehouse, or establishment delays, denies, or limits an inspection, or refuses to permit entry or inspection. Articles of drug falling within this new section are subject to refusal under 801(a)(3) of the FD&C Act. Changes are bracketed by three asterisks (***).
Heparin is a widely used anti-coagulant and is commonly used during surgical procedures and for those undergoing dialysis. There are an estimated 12 million Americans that use heparin each year. In 2008, a number of deaths in the United States were associated with either contaminated or adulterated heparin. The adverse events have included allergic or hypersensitivity-type reactions, with symptoms such as low blood pressure, angioedema, shortness of breath, nausea, diarrhea, and abdominal pain.
The vast majority of crude heparin, heparin intermediates, and heparin API used in finished drug product in the United States is imported from other countries. The phrase "different forms of heparin and heparin-related products" is used for brevity to refer to articles such as crude heparin, heparin intermediates, heparin active pharmaceutical ingredient (API), heparin products, and heparin-containing products.
As part of FDA's activities intended to protect the health and safety of U.S. consumers, FDA often conducts inspections of foreign establishments that produce FDA-regulated articles intended for use in the United States. One basis for detention without physical examination is that the firm's quality system is inadequate for the prevention of contamination or otherwise does not conform to CGMP. Heparin contaminated with oversulfated chondroitin sulfate (OSCS) clearly indicates that the "methods used in" or the "controls used for" the "manufacture, processing, packing, or holding do not conform to or are not operated or administered in conformity" with CGMP. OSCS is not part of the manufacturing process for heparin and its presence suggests that somewhere in the supply chain OSCS has been added intentionally to heparin for financial reasons because it is a very cheap material prepared by a simple synthetic process. In addition, it mimics certain heparin properties so that it would pass then current United States Pharmacopeia (USP) specifications for Heparin Sodium USP. (The USP has since revised in 2009 its monograph for Heparin Sodium USP to incorporate tests that can detect the presence of OSCS).
Manufacturers must have adequate traceability, qualification, and testing systems in place in order to satisfy applicable CGMP requirements. Where there is an inspection that identifies an inadequate system in this regard, the firm's drug(s) or other products appear to be adulterated and are subject to imports refusal per 801(a)(3).
Furthermore, if the firm appears to have been responsible for introducing contaminated forms of heparin or heparin-related products into the supply chain, then there is an appearance that the firm's quality system is inadequate or otherwise does not conform to CGMP. If the firm demonstrates that they have appropriate controls in place, the firm's drugs or other products may no longer appear to be adulterated.
***Another basis for detention without physical examination is that an establishment delays, denies, or limits an FDA inspection, or refuses to permit entry or inspection. In such cases, FDA cannot verify that there are adequate systems in place to safeguard against OSCS and other contamination.
The Food and Drug Administration Safety and Innovation Act (FDASIA) was signed into law on July 9, 2012. Section 707 of FDASIA added a new section 501(j) to the FD&C Act, making a drug adulterated if it has been manufactured, processed, packed, or held in any factory, warehouse, or establishment and the owner, operator, or agency of such factory, warehouse, or establishment delays, denies, or limits an inspection, or refuses to permit entry or inspection. Different forms of heparin or heparin-related products that have been manufactured, processed, packed, or held in any factory, warehouse, or establishment of which the owner, operator, or agent has delayed, denied, or limited an inspection, or refused to permit entry or inspection, appear to be adulterated and are subject to refusal under section 801(a)(3) of the FD&C Act.***
The attachment to this alert identifies firms for which we have information indicating that the different forms of heparin or heparin-related products appear to be adulterated for one of the reasons described above. It appears per 801(a) that the methods used in and controls used for the manufacture, processing, packing, or holding of the drugs or other products from the firms listed in the attachment do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B), ***or that a firm delays, denies, or limits an inspection, or refuses to permit an inspection under 501(j);*** therefore such articles are subject to refusal of admission into the United States. Note: Charge statement revised on 04/23/2019
Heparin is a widely used anti-coagulant and is commonly used during surgical procedures and for those undergoing dialysis. There are an estimated 12 million Americans that use heparin each year. In 2008, a number of deaths in the United States were associated with either contaminated or adulterated heparin. The adverse events have included allergic or hypersensitivity-type reactions, with symptoms such as low blood pressure, angioedema, shortness of breath, nausea, diarrhea, and abdominal pain.
The vast majority of crude heparin, heparin intermediates, and heparin API used in finished drug product in the United States is imported from other countries. The phrase "different forms of heparin and heparin-related products" is used for brevity to refer to articles such as crude heparin, heparin intermediates, heparin active pharmaceutical ingredient (API), heparin products, and heparin-containing products.
As part of FDA's activities intended to protect the health and safety of U.S. consumers, FDA often conducts inspections of foreign establishments that produce FDA-regulated articles intended for use in the United States. One basis for detention without physical examination is that the firm's quality system is inadequate for the prevention of contamination or otherwise does not conform to CGMP. Heparin contaminated with oversulfated chondroitin sulfate (OSCS) clearly indicates that the "methods used in" or the "controls used for" the "manufacture, processing, packing, or holding do not conform to or are not operated or administered in conformity" with CGMP. OSCS is not part of the manufacturing process for heparin and its presence suggests that somewhere in the supply chain OSCS has been added intentionally to heparin for financial reasons because it is a very cheap material prepared by a simple synthetic process. In addition, it mimics certain heparin properties so that it would pass then current United States Pharmacopeia (USP) specifications for Heparin Sodium USP. (The USP has since revised in 2009 its monograph for Heparin Sodium USP to incorporate tests that can detect the presence of OSCS).
Manufacturers must have adequate traceability, qualification, and testing systems in place in order to satisfy applicable CGMP requirements. Where there is an inspection that identifies an inadequate system in this regard, the firm's drug(s) or other products appear to be adulterated and are subject to imports refusal per 801(a)(3).
Furthermore, if the firm appears to have been responsible for introducing contaminated forms of heparin or heparin-related products into the supply chain, then there is an appearance that the firm's quality system is inadequate or otherwise does not conform to CGMP. If the firm demonstrates that they have appropriate controls in place, the firm's drugs or other products may no longer appear to be adulterated.
***Another basis for detention without physical examination is that an establishment delays, denies, or limits an FDA inspection, or refuses to permit entry or inspection. In such cases, FDA cannot verify that there are adequate systems in place to safeguard against OSCS and other contamination.
The Food and Drug Administration Safety and Innovation Act (FDASIA) was signed into law on July 9, 2012. Section 707 of FDASIA added a new section 501(j) to the FD&C Act, making a drug adulterated if it has been manufactured, processed, packed, or held in any factory, warehouse, or establishment and the owner, operator, or agency of such factory, warehouse, or establishment delays, denies, or limits an inspection, or refuses to permit entry or inspection. Different forms of heparin or heparin-related products that have been manufactured, processed, packed, or held in any factory, warehouse, or establishment of which the owner, operator, or agent has delayed, denied, or limited an inspection, or refused to permit entry or inspection, appear to be adulterated and are subject to refusal under section 801(a)(3) of the FD&C Act.***
The attachment to this alert identifies firms for which we have information indicating that the different forms of heparin or heparin-related products appear to be adulterated for one of the reasons described above. It appears per 801(a) that the methods used in and controls used for the manufacture, processing, packing, or holding of the drugs or other products from the firms listed in the attachment do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B), ***or that a firm delays, denies, or limits an inspection, or refuses to permit an inspection under 501(j);*** therefore such articles are subject to refusal of admission into the United States. Note: Charge statement revised on 04/23/2019
Guidance:
Districts may detain without physical examination all forms of heparin and heparin-related products from the firm(s) identified on the attachment to this import alert.
Since the article appears to be adulterated due to inadequate GMPs,*** or delay, denial, limitation, and/or refusal of inspection,***and is subject to Refusal of Admission per Section 801(a)(3) of the Act, FDA considers reconditioning or submission of analytical results to be insufficient to overcome the appearance of the violation.
Drugs and other products offered for importation from the firm(s) listed on the attachment to this import alert are subject to detention without physical examination until FDA is satisfied that the appearance of a violation has been removed, either by inspection, reinspection, submission of documentation, and/or other actions requested by the FDA.
Firms may provide copies of inspection reports for inspections performed by third parties to assist FDA in prioritizing inspection requests. An establishment wishing to schedule an FDA inspection or to provide a copy of an inspection report conducted by a third party, should do so by submitting a request or documentation to the following address:
Food and Drug Administration
Division of Import Operations and Policy (HFC-170)
12420 Parklawn Drive, ELEM-3109
Rockville, MD 20857
Or via email: Importalerts2@fda.hhs.gov
Since the article appears to be adulterated due to inadequate GMPs,*** or delay, denial, limitation, and/or refusal of inspection,***and is subject to Refusal of Admission per Section 801(a)(3) of the Act, FDA considers reconditioning or submission of analytical results to be insufficient to overcome the appearance of the violation.
Drugs and other products offered for importation from the firm(s) listed on the attachment to this import alert are subject to detention without physical examination until FDA is satisfied that the appearance of a violation has been removed, either by inspection, reinspection, submission of documentation, and/or other actions requested by the FDA.
Firms may provide copies of inspection reports for inspections performed by third parties to assist FDA in prioritizing inspection requests. An establishment wishing to schedule an FDA inspection or to provide a copy of an inspection report conducted by a third party, should do so by submitting a request or documentation to the following address:
Food and Drug Administration
Division of Import Operations and Policy (HFC-170)
12420 Parklawn Drive, ELEM-3109
Rockville, MD 20857
Or via email: Importalerts2@fda.hhs.gov
Product Description:
Different Forms of Heparin and Heparin-Related Products (e.g., Crude Heparin, Heparin Intermediates, Heparin Active Pharmaceutical Ingredient (API), Heparin Products, and Heparin-Containing Products) from the firms listed below.
***Product codes:
55R[][][] Crude Heparin
61L[][][] Heparin Sodium***
***Product codes:
55R[][][] Crude Heparin
61L[][][] Heparin Sodium***
Charge:
"The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B)."
OASIS Charge Code: DRUG GMPs
And/or
*** "The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article of drug appears to be adulterated under Section 501(j) because it has been manufactured, processed, packed, or held in any factory, warehouse, or establishment and the owner, operator, or agent of such factory, warehouse, or establishment delays, denies, or limits an inspection, or refuses to permit entry or inspection."
OASIS Charge Code: DRG REF EI ***
***Inspection Refusal***
OASIS Charge Code: DRUG GMPs
And/or
*** "The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article of drug appears to be adulterated under Section 501(j) because it has been manufactured, processed, packed, or held in any factory, warehouse, or establishment and the owner, operator, or agent of such factory, warehouse, or establishment delays, denies, or limits an inspection, or refuses to permit entry or inspection."
OASIS Charge Code: DRG REF EI ***
***Inspection Refusal***
List of firms and their products subject to Detention without Physical Examination (DWPE) under this Import Alert (a.k.a. Red List)
CHINA
Beijing Qianxihe
Date Published : 07/31/2012
Qianxihe Road , Pinggu District
, Beijing,
CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
61 L - - 35 Tinzaparin Sodium (Anti-Coagulant)
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
75 J - - KA Tubes, Vials, Systems, Serum Separators, Blood Collection
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
80 N - - ZW Heparin Vascular access flush
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
81 G - - FO Activated Partial Thromboplastin
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
81 G - - GP Test, Qualitative and Quantitative Factor Deficiency
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
81 G - - GW Test, Time, Partial Thromboplastin
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
81 J - - BP Activated Whole Blood Clotting Time
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop; Use charge code; DRUG GMPs
81 J - - OX Analyzer, Heparin, Automated
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
81 J - - PA System, Multipurpose for in Vitro Coagulation Studies
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
81 K - - FF Assay, Heparin
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
81 L - - CO Platelet Factor 4 Radioimmunoassay
Date Published: 10/07/2022
Desc: Heparin and Heparin-Related Products
Notes: Alias Beijing Pinggu Workshop;
Use charge code; DRUG GMPs
Beijing Shunxin Meihua Bio-technical Co., Ltd.
Date Published : 07/22/2014
No 7 Fuqiandongjie , Shunyizhen
, Shunyi,
Beijing CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 07/22/2014
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs and DRG REF EI; Firm refused FDA inspection
61 L - - -- A-Coagulant
Date Published: 07/22/2014
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs and DRG REF EI; Firm refused FDA inspection
Casing Factory Jintan City
Date Published : 02/22/2012
Jin Chen , 7 Beihuan West Rd; Jintan
, Changzhou,
Jiangsu CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Aliases;Jintan Yongmao Casing Co. LtdJintan Caliber Casing Co. Ltd;Notes:
Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Aliases; Jintan Yongmao Casing Co. Ltd Jintan Caliber Casing Co.
Ltd;Notes: Use charge code: DRUG GMPs
Changsha Wulipai Food Stuff Factory
Date Published : 02/22/2012
"No 8 Bayi East Rd
, Changsha,
Hunan CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Changzhou SPL Company, Ltd.
Date Published : 02/22/2012
West Rd. , Hutang Township, Wujin City
, Changzhou City,
Jiangsusheng CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Chongqing Baijie Changhong Casing Co., Ltd
Date Published : 04/04/2012
Baijie,
, Chongqing,
CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 35 Tinzaparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
Chongqing Imperial Bio Chem Co
Date Published : 02/22/2012
Citic Bank 19-7 , 5 Yanghesancun
, Jiangbei,
Chongqing CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Chongqing Paiquiang Agribyproduct Co., Ltd
Date Published : 02/22/2012
158 Gonglongpo , Yudong
, Chongqing,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Heilongjiang Yuanguang Casing Co.,Ltd.
Date Published : 02/22/2012
7 Bohai East Road Jizhong District, Haping Road , Economic-Technology Development District
, Harbin,
Heilongjiang CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Alias;Heilongjiang Yuanguang Caliber Casing Co.; LtdAlternate
Address;No.7 Bohai East Road;Jizhong District Heilongjiang China; Notes:
Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Alias;
Heilongjiang Yuanguang
Caliber Casing Co.; Ltd
Alternate Address;
No.7 Bohai East Road;
Jizhong District Heilongjiang
China
;Notes: Use charge code: DRUG GMPs
Henan Zhengping Huixin
Date Published : 02/22/2012
Fuzhuang Yangying Town , "Zhengping,
, Henan,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Aliases;Henan Zhengping Huixin;Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Aliases;
Henan Zhengping Huixin
;Notes: Use charge code: DRUG GMPs
Hubei Anlu Food Stuff Factory
Date Published : 02/22/2012
Xinli Village, Zhuzhan Town , Xiaogan City,
, Hubei,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 04/26/2023
Desc: Heparin and Heparin-related products
Notes: Use charge code; DRUG GMPs
Jiangsu Long Life Group
Date Published : 02/22/2012
No. 216 Renshou Rd , Town, Rugao
, Rucheng,
Jiangsu CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Jianyang Jiajia Livestock Processing Plant
Date Published : 08/06/2012
Dunjinmaio , Jiajia Township
, Jianyang,
Sichuan CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
61 L - - 35 Tinzaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
75 J - - KA Tubes, Vials, Systems, Serum Separators, Blood Collection
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
80 N - - ZW Heparin Vascular access flush
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
81 G - - FO Activated Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
81 G - - GP Test, Qualitative and Quantitative Factor Deficiency
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
81 G - - GW Test, Time, Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
81 J - - BP Activated Whole Blood Clotting Time
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
81 J - - OX Analyzer, Heparin, Automated
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
81 J - - PA System, Multipurpose for in Vitro Coagulation Studies
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
81 K - - FF Assay, Heparin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
81 L - - CO Platelet Factor 4 Radioimmunoassay
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 8/6/2012
Junan Hengxing Foodstuff Co., Ltd
Date Published : 02/22/2012
No. 126 Meishan Rd , Ju'nan County,
, Shandong,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Lianyungang Furun Food Co. Ltd.
Date Published : 07/31/2012
8 Yurun Road , Donghai County
, Liangyngang City,
CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang
Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop;
Notes; Use charge code; DRUG GMPs; 8/1/2012
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 35 Tinzaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
75 J - - KA Tubes, Vials, Systems, Serum Separators, Blood Collection
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
80 N - - ZW Heparin Vascular access flush
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - FO Activated Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - GP Test, Qualitative and Quantitative Factor Deficiency
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - GW Test, Time, Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - BP Activated Whole Blood Clotting Time
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - OX Analyzer, Heparin, Automated
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products Notes; Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - PA System, Multipurpose for in Vitro Coagulation Studies
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 K - - FF Assay, Heparin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 L - - CO Platelet Factor 4 Radioimmunoassay
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
Lianyungang Furun Food Co., LTD
Date Published : 07/31/2012
8 West Xuhai Road
, Donghai,
Jiangsu CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang
Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop;
Notes; Use charge code; DRUG GMPs; 8/1/2012
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang
Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop;
Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 35 Tinzaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
75 J - - KA Tubes, Vials, Systems, Serum Separators, Blood Collection
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
80 N - - ZW Heparin Vascular access flush
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - FO Activated Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - GP Test, Qualitative and Quantitative Factor Deficiency
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - GW Test, Time, Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - BP Activated Whole Blood Clotting Time
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - OX Analyzer, Heparin, Automated
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - PA System, Multipurpose for in Vitro Coagulation Studies
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 K - - FF Assay, Heparin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 L - - CO Platelet Factor 4 Radioimmunoassay
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Jiangsu Furun Meat Process Co.; Ltd.; Lianyungang Donghai Workshop; Donghai Workshop; Donghai Crude Heparin Workshop; Notes; Use charge code; DRUG GMPs; 8/1/2012
Nanjing Maohai Biotech Co.
Date Published : 02/22/2012
8 Developing Zone , Yaxi Town, Gaochun County
, Nanjing Jiangsu Province,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Nantong Jianhua Casing Co. Ltd
Date Published : 02/22/2012
Linjiang Village/Langshan Town, , Nantong,
, Jiangsu,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Nantong Tianlong Animal By-products Co., Ltd
Date Published : 07/31/2012
Dingyan , 9 Ding Xinlu; Rugao
, Nantong,
Jiangsu CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
61 L - - 35 Tinzaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
75 J - - KA Tubes, Vials, Systems, Serum Separators, Blood Collection
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
80 N - - ZW Heparin Vascular access flush
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
81 G - - FO Activated Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
81 G - - GP Test, Qualitative and Quantitative Factor Deficiency
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
81 G - - GW Test, Time, Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
81 J - - BP Activated Whole Blood Clotting Time
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
81 J - - OX Analyzer, Heparin, Automated
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
81 J - - PA System, Multipurpose for in Vitro Coagulation Studies
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
81 K - - FF Assay, Heparin
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
81 L - - CO Platelet Factor 4 Radioimmunoassay
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Use charge code; DRUG GMPs; 8/1/2012
Nantong Tianlong Livestock Products
Date Published : 07/31/2012
9 Ding Xin Road , Rugao
, Nantong,
Jiangsu CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.;
Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772;
Notes; Use charge code; DRUG GMPs; 8/1/2012
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 35 Tinzaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
75 J - - KA Tubes, Vials, Systems, Serum Separators, Blood Collection
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
80 N - - ZW Heparin Vascular access flush
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - FO Activated Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - GP Test, Qualitative and Quantitative Factor Deficiency
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - GW Test, Time, Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - BP Activated Whole Blood Clotting Time
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - OX Analyzer, Heparin, Automated
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - PA System, Multipurpose for in Vitro Coagulation Studies
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 K - - FF Assay, Heparin
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
81 L - - CO Platelet Factor 4 Radioimmunoassay
Date Published: 10/20/2022
Desc: Heparin and Heparin Related Products
Notes: Firm aliases; Nantong; Nantong Kelong Biological Products Co. Ltd.; Nantong Tianlong Animal By Products Co.; Ltd FEI #3008975772; Notes; Use charge code; DRUG GMPs; 8/1/2012
Qingdao Hualu Foods Co., Ltd
Date Published : 02/22/2012
Industrial Park of Jiaodong Town , Jiaozhou,
, Qingdao,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 04/26/2023
Desc: Heparin and Heparin-related products
Notes: Use charge code; DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Shandong Union Food Stuff Qingzhou Branch*
Date Published : 02/22/2012
Mojiacun Subu Town , Qingzhou,
, Shandong,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Aliases;Qingzhou United;Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Aliases;
Qingzhou United;
Notes: Use charge code: DRUG GMPs
Shanghai Biochemial And Pharmaceutical Co Ltd
Date Published : 02/22/2012
Room A403, No. 494 Zhongxing Road
, Shanghai,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Shanghai Henchang Grease & Casing Factory
Date Published : 07/31/2012
227 Xuguo , Ducun Village
, Qingpu District,
Shanghai CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai
Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu
Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
75 J - - KA Tubes, Vials, Systems, Serum Separators, Blood Collection
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
80 N - - ZW Heparin Vascular access flush
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - FO Activated Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - GP Test, Qualitative and Quantitative Factor Deficiency
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - GW Test, Time, Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - BP Activated Whole Blood Clotting Time
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - OX Analyzer, Heparin, Automated
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - PA System, Multipurpose for in Vitro Coagulation Studies
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 K - - FF Assay, Heparin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 L - - CO Platelet Factor 4 Radioimmunoassay
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm aliases; Shanghai Qingpu Crude Heparin Workshop; Shanghai Qingpu; Hangzhou Ruihua Qingpu Crude Heparin Workshop; Qingpu Workshop;Notes; Use charge code; DRUG GMPs; 8/1/2012
Shanghai Nanxiang Crude Heparin Plant
Date Published : 07/31/2012
Jiading
, Jiading,
Shanghai CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai;
Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 35 Tinzaparin Sodium (Anti-Coagulant)
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
75 J - - KA Tubes, Vials, Systems, Serum Separators, Blood Collection
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
80 N - - ZW Heparin Vascular access flush
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - FO Activated Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - GP Test, Qualitative and Quantitative Factor Deficiency
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 G - - GW Test, Time, Partial Thromboplastin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - BP Activated Whole Blood Clotting Time
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - OX Analyzer, Heparin, Automated
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 J - - PA System, Multipurpose for in Vitro Coagulation Studies
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 K - - FF Assay, Heparin
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
81 L - - CO Platelet Factor 4 Radioimmunoassay
Date Published: 10/20/2022
Desc: Heparin and Heparin-Related Products
Notes: Firm Alias- Shanghai Nanxiang Crude Heparin Workshop; Shanghai; Nanxian; China;Notes; Use charge code; DRUG GMPs; 8/1/2012
Shanghai No. 1 Biochemical & Pharmaceutical Co., Ltd.
Date Published : 02/22/2012
1317 Jianchuanlu , Minhang District
, Shanghai,
Shanghai CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Shanghai No. 1 Biochemical & Pharmaceutical Co., Ltd.
Date Published : 02/22/2012
387 Shangqiulu
, Shanghai,
Shanghai CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Sichuan Shuangliu Food Stuff Factory
Date Published : 02/22/2012
61 Wujiaba Nort Street , Shuangliu,
, Sichuan,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Sichuan Zhongjiang Xiongjian Casing Co.
Date Published : 04/04/2012
"Kanjiang, , Zhongjiang,
, Sichuan,
CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 35 Tinzaparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
Weifang Legang Food Ltd.
Date Published : 02/22/2012
No. 1 Honghe Street , Honghe Town, Changle County
, Weifang Shandong,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Xinjiang Lanshanbinggong Food Factory
Date Published : 02/22/2012
No31 QinjianRoad , Gumudi Town, Miquan City,
, Xinjiang,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Xuzhou City Mianshang Fengxian Shengda Casing Factory
Date Published : 02/22/2012
Zhangshicheng Village , Zhaozhuang Town
, Xuzhou Jiangsu,
CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Yibin Lihao Bio-technical Co., Ltd.
Date Published : 01/15/2020
Luolong Industrial Central Park , No. 5 Bin Jiang Road; Nanxixian
, Yibin,
Sichuan CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 01/15/2020
Desc: Heparin and Heparin-Related Products
Notes: Use Charge Code: DRUG GMPS
61 L - - -- A-Coagulant
Date Published: 01/15/2020
Desc: Heparin and Heparin-Related Products
Notes: Use Charge Code: DRUG GMPS
Zhejiang Casing Animal By-Products Co.,Ltd.
Date Published : 02/22/2012
Tonglu Economic , 369 Dongxing Road; Tongluxian
, Hangzhou,
Zhejiang CHINA
55 R - - -- Pharm Nec (Mfr)
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
61 L - - -- A-Coagulant
Date Published: 02/22/2012
Desc: Heparin and Heparin-related products
Notes: Notes: Use charge code: DRUG GMPs
Zhengzhou Yuanlong Casing Co., Ltd
Date Published : 04/04/2012
"Renmin Road, , Zhengzhou,
, Henan,
CHINA
55 R - - 75 Crude Heparin (Pharmaceutic Necessity)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
55 R - - 99 Pharmaceutic Necessities, N.E.C.
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 08 Heparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 22 Anti-Coagulant Heparin Sol
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 26 Ardeparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 27 Dalteparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 29 Enoxaparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 30 Heparin Calcium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 35 Tinzaparin Sodium (Anti-Coagulant)
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
61 L - - 99 Anti-Coagulant, N.E.C.
Date Published: 10/18/2022
Desc: Heparin and Heparin-Related Products
Notes: Use charge code; DRUG GMPs; 4/4/2012
THAILAND
Mei Lan (Thailand) Company, Ltd.
Date Published : 01/18/2024
35/252-253 Moo 2
, Muang Samut Sakhon,
Samut Sakhon THAILAND
55 R - - -- Pharm Nec (Mfr)
Date Published: 01/18/2024
Desc: Heparin and Heparin-Related Products
Notes: Use charge code DRG REF EI as firm refused FDA inspection.
61 L - - -- A-Coagulant
Date Published: 01/18/2024
Desc: Heparin and Heparin-Related Products
Notes: Use charge code DRG REF EI as firm refused FDA inspection.